NRX Pharmaceuticals, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2020 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
NRX Pharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2020 to 2022.
  • NRX Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $104K, a 70.4% decline year-over-year.
  • NRX Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $2.32M, a 70.2% decline from 2021.
  • NRX Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $7.79M, a 966% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $2.32M -$5.46M -70.2% Jan 1, 2022 Dec 31, 2022 10-Q 2023-08-14
2021 $7.79M +$7.06M +966% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 $730K Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.